US 10238735
Controlled activation of complement components for use as endogenous adjuvant
granted A61KA61K2039/55516A61K39/292
Quick answer
US patent 10238735 (Controlled activation of complement components for use as endogenous adjuvant) held by PLS-Design GmbH expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PLS-Design GmbH
- Grant date
- Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/55516, A61K39/292, A61K39/39, A61K9/0024